retatrutide nejm 2023 obesity trial ly3437943 Results from a new of (LY3437943; Eli Lilly) found that participants had considerable decreases in body weight at week 48, although this depended on the dose and varied due to Early trial data for retatrutide

US$ 23.67

★★★★★ 4.0 (23 reviews)

US$ 24.15

★★★★★ 4.6 (22 reviews)

US$ 25.76

★★★★★ 4.1 (21 reviews)

US$ 27.37

★★★★★ 4.3 (6 reviews)

US$ 27.07

★★★★★ 5.0 (14 reviews)

US$ 24.60

★★★★★ 4.6 (27 reviews)

US$ 24.70

★★★★★ 4.3 (18 reviews)

US$ 21.15

★★★★★ 4.1 (25 reviews)

US$ 23.76

★★★★★ 4.5 (7 reviews)

US$ 27.19

★★★★★ 4.0 (21 reviews)

US$ 20.91

★★★★★ 4.9 (16 reviews)

US$ 27.73

★★★★★ 4.1 (26 reviews)

US$ 27.48

★★★★★ 4.0 (20 reviews)

US$ 22.49

★★★★★ 4.9 (28 reviews)

US$ 27.37

★★★★★ 4.3 (15 reviews)

US$ 29.49

★★★★★ 4.1 (23 reviews)

US$ 24.58

★★★★★ 4.2 (13 reviews)

US$ 28.45

★★★★★ 4.3 (21 reviews)

US$ 25.62

★★★★★ 4.6 (5 reviews)

US$ 26.83

★★★★★ 4.8 (30 reviews)